Anpario (LON:ANP) Given “House Stock” Rating at Shore Capital Group

Anpario (LON:ANP – Get Free Report)‘s stock had its “house stock” rating reaffirmed by equities researchers at Shore Capital Group in a research report issued to clients and investors on Thursday,Digital Look reports.

Separately, Canaccord Genuity Group raised shares of Anpario to a “buy” rating and boosted their target price for the stock from GBX 457 to GBX 570 in a research report on Thursday, April 2nd. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of GBX 570.

Get Anpario alerts:

Check Out Our Latest Analysis on ANP

Anpario Stock Down 1.4%

LON:ANP opened at GBX 510 on Thursday. The company has a market cap of £84.46 million, a PE ratio of 13.44 and a beta of 1.05. Anpario has a twelve month low of GBX 370 and a twelve month high of GBX 580. The company has a current ratio of 4.50, a quick ratio of 5.16 and a debt-to-equity ratio of 0.60. The company’s 50 day moving average is GBX 525.11 and its two-hundred day moving average is GBX 508.65.

Anpario declared that its board has initiated a stock repurchase plan on Monday, April 27th that permits the company to repurchase 0 shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Stories

• Five stocks we like better than Anpario
• Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
• CoreWeave Insider Sales Look Big, But Should Investors Worry?
• Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
• Meta and Cloud Computing: Real Potential, or a Shot in the Dark?

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.